Health-related quality of life in dialysis patients with HCV infection

International Journal of Artificial Organs

Volumn 32, Issue 8, 2009, Pages 473-481

  Fabrizi, Fabrizio ^a,b   Messa, Piergiorgio ^a   Martin, Paul ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Dialysis; Health related quality of life (HRQOL); Hepatitis C virus (HCV); Survival

Indexed keywords

DIALYSIS; DISEASES; HEALTH RISKS; HOSPITALS; MAINTENANCE; PATIENT TREATMENT; RISK ASSESSMENT; VIRUSES;

CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; HEALTH-RELATED QUALITY OF LIFE; HEALTH-RELATED QUALITY OF LIVES; HEPATITIS C VIRUS; PHYSICAL COMPONENTS; RELATIVE RISKS; SURVIVAL; VIRUS INFECTION;

RISK PERCEPTION;

INTERFERON;

CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAINTENANCE THERAPY; PERITONEAL DIALYSIS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SHORT FORM 36; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

ADAPTATION, PSYCHOLOGICAL; COST OF ILLNESS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 70350539704     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880903200801     Document Type: Review

References (50)

1. Jofre R, Lopez-Gomez G, Valderrabano F. Quality of life for patient groups. Kidney Int 2000; 57 (Suppl 74): S121-30.
2. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-266.
3. Desai AA, Garber AM, Chertow G. Rise for pay for performance: Implications for care of people with chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1087-95.
4. Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol 2008; 49: 613-24.
5. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int 2008; 73 (Suppl 109): S1-99.
6. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 2007; 14: 697-703.
7. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209-12.
8. Bayliss MS, Gandek B, Bungay K, Sugano D, Hsu M, Ware JE. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998; 7: 39-55.
9. McHorney CA, Ware JE, Raczek E. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
10. Ware J, Bayliss M, Mannocchia M, Davis GL, and The International Hepatitis Interventional Therapy Group. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 1999; 30: 550-55.
11. Bonkovsky HL, Woolley JM; The Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999; 29: 264-70.
12. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok ASF. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 2737-44.
13. McHutchison JG, Ware JE, Bayliss MS, et al; The Hepatitis Interventional Therapy Group. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001; 34: 140-7.
14. Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37: 349-54.
15. Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231-8.
16. Fleming CA, Christiansen D, Nunes D, et al. Health related quality of life on patients with HIV disease: impact of hepatitis C co-infection. Clin Infect Dis 2004; 38: 572-8.
17. Heitkemper M, Jarrett M, Kurashige EM, Carithers R. Chronic hepatitis C: Implications for health-related quality of life. Gastroenterol Nurs 2001; 24: 169-75.
18. Mapes DL, Lopes A, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: The dialysis outcomes and practice patterns study (DOPPS). Kidney Int 2003; 64: 339-49.
19. Finelli L, Miller JT, Tokars JI, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
20. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-7.
21. Maisonneuve P, Agodoa L, Geller R, et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999; 354: 93-9.
22. Kalantar-Zadeh K, Kilpatrick R, McAllister C, et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 2007; 18: 1584-93.
23. Afsar B, Elsurer R, Sezer S, Ozdemir NF. Quality of life in hemodialysis patients: hepatitis C virus makes sense. Int Urol Nephrol 2009 May 9 (Epub ahead of print) DOI 10.1007/s11255-009-9576-3
24. Kurella M, Luan J, Yaffe K, Chertow G. Validation of the kidney disease quality of life (KDQOL) cognitive function subscale. Kidney Int 2004; 66: 2361-7.
25. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, NECOSAD study group. Validation of the KDQOL-SF: A dialysis-targeted health measure. Qual Life Res 2002; 11: 437-47.
26. Carmichel P, Popoola J, John I, Stevens PE, Carmichel AR. Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire. Qual Life Res 2000; 9: 195-205.
27. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gusbarrini G. HCV infection and extrahepatic manifestations. Hepatogastroenterology 2003; 50: 1149-54.
28. Stojanovic M, Ilic S, Stefanovic V. Influence of co-morbidity on health-related quality of life in patients treated with hemodialysis. Int J Artif Organs 2006; 29: 1053-61.
29. Coughlan B, Sheenan J, Hickey A, Crowe J. Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. Br J Health Psychol 2002; 7: 105-16.
30. Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002; 36: S1-2.
31. Spiegel B, Younossi Z, Hays R, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: review and quantitative assessment. Hepatology 2005; 41: 790-800.
32. Kalantar-Zadeh K, Kopple JD, Block G, Humpreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001; 12: 2797-2806.
33. Morsch CM, Goncalves LF, Barros E. Health-related quality of life among hemodialysis patients- relationship with clinical indicators, morbidity and mortality. J Clin Nurs 2006; 15: 498-504.
34. Mau LW, Chiu HC, Chang PY, Hwang SC, Hwang SJ. Health-related quality of life in Taiwanese dialysis patients: effects of dialysis modality. Kaohsiung J Med Sci 2008; 24: 453-60.
35. Bakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int 2002; 61: 239-48.
36. Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G, for the DIA-QOL group. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. Nephrol Dial Transplant 1999; 14: 1503-10.
37. Bahlke M, Nunes DL, Marini S, Kitamura C, Andrade M, Van-Gysel MP. Predictors of quality of life among patients on dialysis in southern Brazil. San Paulo Med J 2008; 126: 252-6.
38. Chiang CK, Peng YS, Chiang SS, et al. Health-related quality of life in hemodialysis patients in Taiwan: a multicenter study. Blood Purif 2004; 22: 490-8.
39. Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, Lopez-Revuelta K, De Alvaro F, Cruzado JM; Spanish CALVIDIA Study Group. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol 2004; 17: 544-51.
40. Fukuhara S, Lopes A, Bragg-Gresham JL, et al, for the Worldwide DOPPS. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 64: 1903-10.
41. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-98.
42. Spiegel B, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: A systematic review. Clin J Am Soc Nephrol 2008; 3: 1759-68.
43. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired-immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28: 1398-401.
44. Bolay H, Soylemezoglu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996; 98: 305-8.
45. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358: 38-9.
46. Fukuhara S, Green J, Albert J, et al. Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int 2006; 70: 1866-72.
47. Walters BA, Hays RD, Spritzer KL, Fridman M, Carter WB. Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis 2002; 40: 1185-94.
48. Turk S, Atalay H, Altinpepe L, et al. Treatment with anti-depressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol 2006; 65: 113-8.
49. Gallegos-Orozco JF, Fuentes AP, Gerardo Argueta J, et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003; 34: 124-9.
50. Fukuhara S, Yamazaki S, Hayashino Y, Green J. Measuring health-related quality of life in patients with endstage renal disease: why and how. Nat Clin Pract Nephrol 2007; 3: 352-3.